These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19002424)

  • 1. Permanent silencing of NKG2A expression for cell-based therapeutics.
    Figueiredo C; Seltsam A; Blasczyk R
    J Mol Med (Berl); 2009 Feb; 87(2):199-210. PubMed ID: 19002424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
    Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
    Kamiya T; Seow SV; Wong D; Robinson M; Campana D
    J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
    Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
    Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
    Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
    Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia.
    Chang MC; Cheng HI; Hsu K; Hsu YN; Kao CW; Chang YF; Lim KH; Chen CG
    Front Immunol; 2018; 9():3152. PubMed ID: 30705677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
    Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-3 is an important transcription factor for regulating human NKG2A gene expression.
    Marusina AI; Kim DK; Lieto LD; Borrego F; Coligan JE
    J Immunol; 2005 Feb; 174(4):2152-9. PubMed ID: 15699146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody.
    Gong Y; Germeraad WTV; Zhang X; Wu N; Li B; Janssen L; He Z; Gijbels MJJ; Wu B; Gijsbers BLMG; Olieslagers TI; Bos GMJ; Zheng L; Klein Wolterink RGJ
    Mol Ther; 2024 Aug; 32(8):2711-2727. PubMed ID: 38943249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
    Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
    Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect.
    Nguyen S; Dhedin N; Vernant JP; Kuentz M; Al Jijakli A; Rouas-Freiss N; Carosella ED; Boudifa A; Debré P; Vieillard V
    Blood; 2005 May; 105(10):4135-42. PubMed ID: 15687235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
    Walsh CE; Ryan EJ; O'Farrelly C; Golden-Mason L; FitzGerald O; Veale DJ; Bresnihan B; Fearon U
    PLoS One; 2011; 6(11):e27182. PubMed ID: 22102879
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
    Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
    J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.
    Bryceson YT; Ljunggren HG; Long EO
    Blood; 2009 Sep; 114(13):2657-66. PubMed ID: 19628705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.